Transcutaneous antigen delivery system

BMB Rep. 2013 Jan;46(1):17-24. doi: 10.5483/bmbrep.2013.46.1.001.

Abstract

Transcutaneous immunization refers to the topical application of antigens onto the epidermis. Transcutaneous immunization targeting the Langerhans cells of the skin has received much attention due to its safe, needle-free, and noninvasive antigen delivery. The skin has important immunological functions with unique roles for antigen-presenting cells such as epidermal Langerhans cells and dermal dendritic cells. In recent years, novel vaccine delivery strategies have continually been developed; however, transcutaneous immunization has not yet been fully exploited due to the penetration barrier represented by the stratum corneum, which inhibits the transport of antigens and adjuvants. Herein we review recent achievements in transcutaneous immunization, focusing on the various strategies for the enhancement of antigen delivery and vaccination efficacy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adjuvants, Immunologic / chemistry
  • Adjuvants, Immunologic / metabolism
  • Administration, Cutaneous
  • Antigens / administration & dosage*
  • Antigens / immunology
  • CpG Islands
  • Drug Carriers / chemistry*
  • Exotoxins / chemistry
  • Exotoxins / metabolism
  • Humans
  • Skin / immunology
  • Toll-Like Receptors / chemistry
  • Toll-Like Receptors / metabolism
  • Vaccination

Substances

  • Adjuvants, Immunologic
  • Antigens
  • Drug Carriers
  • Exotoxins
  • Toll-Like Receptors